Natco has received approval from the Central Drugs Standard Control Organisation to manufacture the generic version of Semaglutide, with the launch expected in March 2026.
Natco has received approval from the Central Drugs Standard Control Organisation to manufacture the generic version of Semaglutide, with the launch expected in March 2026.